A detailed history of Jane Street Group, LLC transactions in Immutep LTD stock. As of the latest transaction made, Jane Street Group, LLC holds 80,489 shares of IMMP stock, worth $155,343. This represents 0.0% of its overall portfolio holdings.

Number of Shares
80,489
Previous 125,582 35.91%
Holding current value
$155,343
Previous $252,000 29.76%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$1.77 - $2.64 $79,814 - $119,045
-45,093 Reduced 35.91%
80,489 $177,000
Q2 2024

Aug 14, 2024

BUY
$1.87 - $3.23 $234,838 - $405,629
125,582 New
125,582 $252,000
Q4 2023

Feb 14, 2024

BUY
$1.76 - $2.49 $92,343 - $130,645
52,468 New
52,468 $125,000
Q4 2022

Feb 14, 2023

BUY
$1.6 - $2.53 $34,856 - $55,116
21,785 New
21,785 $38,000

Others Institutions Holding IMMP

About IMMUTEP Ltd


  • Ticker IMMP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,624,000
  • Market Cap $167M
  • Description
  • Immutep Limited, a biotechnology company, engages in the research and development of pharmaceutical product candidates. The company develops immunotherapeutic products for the treatment of cancer and autoimmune diseases. Its lead product candidate is eftilagimod alpha (efti or IMP321), a recombinant protein that is in Phase IIb clinical trial as...
More about IMMP
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.